HER2-Positive Breast Cancer.

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing...

Full description

Bibliographic Details
Main Author: Hurvitz, Sara
Corporate Author: ScienceDirect (Online service)
Other Authors: McCann, Kelly
Format: eBook
Language:English
Published: Philadelphia : Elsevier, 2018.
Subjects:
Online Access:Connect to the full text of this electronic book
Description
Summary:Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists. Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive. Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations. Includes a timely section on innovative future therapies.
Item Description:SURGICAL RESECTION.
Physical Description:1 online resource (265 pages)
ISBN:9780323581233
0323581234